| Prevalence | Very rare; estimated <1 per 1,000,000 worldwide |
| Inheritance | Autosomal recessive - requires two mutant alleles |
| Age of onset | Typically 40-60 years (range: 20-70 years) |
| Ethnic distribution | More common in Ashkenazi Jewish population (carrier frequency ~1:10) |
| Sex distribution | Equal males and females |
| Common mutations | Y329S, P378L (common in Ashkenazi Jewish patients) |
| Enzyme activity | Typically 10-30% of normal in affected individuals |
| Peripheral neuropathy | Distal symmetric polyneuropathy, sensory loss, reduced reflexes |
| Muscle weakness | Progressive proximal weakness, difficulty walking |
| Cognitive impairment | Memory problems, executive dysfunction, dementia |
| Urinary incontinence | Neurogenic bladder, urgency, frequency |
| Fatigue | Exercise intolerance, easy fatigability |
| Databases | OMIMOrphanetClinicalTrialsPubMed |
No comments yet. Be the first to comment!
No comments yet. Be the first to comment!